BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 25450608)

  • 1. Further evaluation of [11C]MP-10 as a radiotracer for phosphodiesterase 10A: PET imaging study in rhesus monkeys and brain tissue metabolite analysis.
    Lin SF; Labaree D; Chen MK; Holden D; Gallezot JD; Kapinos M; Teng JK; Najafzadeh S; Plisson C; Rabiner EA; Gunn RN; Carson RE; Huang Y
    Synapse; 2015 Feb; 69(2):86-95. PubMed ID: 25450608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical evaluation of [(18)F]JNJ42259152 as a PET tracer for PDE10A.
    Celen S; Koole M; Ooms M; De Angelis M; Sannen I; Cornelis J; Alcazar J; Schmidt M; Verbruggen A; Langlois X; Van Laere K; Andrés JI; Bormans G
    Neuroimage; 2013 Nov; 82():13-22. PubMed ID: 23664955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preclinical evaluation of 18F-JNJ41510417 as a radioligand for PET imaging of phosphodiesterase-10A in the brain.
    Celen S; Koole M; De Angelis M; Sannen I; Chitneni SK; Alcazar J; Dedeurwaerdere S; Moechars D; Schmidt M; Verbruggen A; Langlois X; Van Laere K; Andrés JI; Bormans G
    J Nucl Med; 2010 Oct; 51(10):1584-91. PubMed ID: 20847170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiosynthesis and in vivo evaluation of [(11)C]MP-10 as a positron emission tomography radioligand for phosphodiesterase 10A.
    Plisson C; Salinas C; Weinzimmer D; Labaree D; Lin SF; Ding YS; Jakobsen S; Smith PW; Eiji K; Carson RE; Gunn RN; Rabiner EA
    Nucl Med Biol; 2011 Aug; 38(6):875-84. PubMed ID: 21843784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical evaluation of a promising C-11 labeled PET tracer for imaging phosphodiesterase 10A in the brain of living subject.
    Liu H; Jin H; Yue X; Zhang X; Yang H; Li J; Flores H; Su Y; Perlmutter JS; Tu Z
    Neuroimage; 2015 Nov; 121():253-62. PubMed ID: 26216275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of [
    Yang KC; Stepanov V; Amini N; Martinsson S; Takano A; Nielsen J; Bundgaard C; Bang-Andersen B; Grimwood S; Halldin C; Farde L; Finnema SJ
    Eur J Nucl Med Mol Imaging; 2017 Feb; 44(2):308-320. PubMed ID: 27817159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphodiesterase 10A PET radioligand development program: from pig to human.
    Plisson C; Weinzimmer D; Jakobsen S; Natesan S; Salinas C; Lin SF; Labaree D; Zheng MQ; Nabulsi N; Marques TR; Kapur S; Kawanishi E; Saijo T; Gunn RN; Carson RE; Rabiner EA
    J Nucl Med; 2014 Apr; 55(4):595-601. PubMed ID: 24614221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiosynthesis and initial characterization of a PDE10A specific PET tracer [18F]AMG 580 in non-human primates.
    Hwang DR; Hu E; Allen JR; Davis C; Treanor J; Miller S; Chen H; Shi B; Narayanan TK; Barret O; Alagille D; Yu Z; Slifstein M
    Nucl Med Biol; 2015 Aug; 42(8):654-63. PubMed ID: 25935386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical Evaluation of 18F-PF-05270430, a Novel PET Radioligand for the Phosphodiesterase 2A Enzyme.
    Chen L; Nabulsi N; Naganawa M; Zasadny K; Skaddan MB; Zhang L; Najafzadeh S; Lin SF; Helal CJ; Boyden TL; Chang C; Ropchan J; Carson RE; Villalobos A; Huang Y
    J Nucl Med; 2016 Sep; 57(9):1448-53. PubMed ID: 27199356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of
    Nabulsi NB; Holden D; Zheng MQ; Bois F; Lin SF; Najafzadeh S; Gao H; Ropchan J; Lara-Jaime T; Labaree D; Shirali A; Slieker L; Jesudason C; Barth V; Navarro A; Kant N; Carson RE; Huang Y
    J Nucl Med; 2019 Aug; 60(8):1147-1153. PubMed ID: 30733324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain PET measurement of PDE10A occupancy by TAK-063, a new PDE10A inhibitor, using [11 C]T-773 in nonhuman primates.
    Takano A; Stepanov V; Nakao R; Amini N; Gulyás B; Kimura H; Halldin C
    Synapse; 2016 Jun; 70(6):253-63. PubMed ID: 26878349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid identification of a novel small molecule phosphodiesterase 10A (PDE10A) tracer.
    Hu E; Ma J; Biorn C; Lester-Zeiner D; Cho R; Rumfelt S; Kunz RK; Nixey T; Michelsen K; Miller S; Shi J; Wong J; Hill Della Puppa G; Able J; Talreja S; Hwang DR; Hitchcock SA; Porter A; Immke D; Allen JR; Treanor J; Chen H
    J Med Chem; 2012 May; 55(10):4776-87. PubMed ID: 22548439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A human [(11)C]T-773 PET study of PDE10A binding after oral administration of TAK-063, a PDE10A inhibitor.
    Takano A; Stenkrona P; Stepanov V; Amini N; Martinsson S; Tsai M; Goldsmith P; Xie J; Wu J; Uz T; Halldin C; Macek TA
    Neuroimage; 2016 Nov; 141():10-17. PubMed ID: 27423256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a series of novel carbon-11 labeled PDE10A inhibitors.
    Stepanov V; Miura S; Takano A; Amini N; Nakao R; Hasui T; Nakashima K; Taniguchi T; Kimura H; Kuroita T; Halldin C
    J Labelled Comp Radiopharm; 2015 May; 58(5):202-8. PubMed ID: 25891816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of a novel PDE10A PET radioligand, [(11) C]T-773, in nonhuman primates: brain and whole body PET and brain autoradiography.
    Takano A; Stepanov V; Gulyás B; Nakao R; Amini N; Miura S; Kimura H; Taniguchi T; Halldin C
    Synapse; 2015 Jul; 69(7):345-55. PubMed ID: 25892433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiosynthesis and in vivo evaluation of [11C]MP-10 as a PET probe for imaging PDE10A in rodent and non-human primate brain.
    Tu Z; Fan J; Li S; Jones LA; Cui J; Padakanti PK; Xu J; Zeng D; Shoghi KI; Perlmutter JS; Mach RH
    Bioorg Med Chem; 2011 Mar; 19(5):1666-73. PubMed ID: 21315609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantification of 18F-JNJ-42259152, a novel phosphodiesterase 10A PET tracer: kinetic modeling and test-retest study in human brain.
    Van Laere K; Ahmad RU; Hudyana H; Dubois K; Schmidt ME; Celen S; Bormans G; Koole M
    J Nucl Med; 2013 Aug; 54(8):1285-93. PubMed ID: 23843566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery and development of 11C-Lu AE92686 as a radioligand for PET imaging of phosphodiesterase10A in the brain.
    Kehler J; Kilburn JP; Estrada S; Christensen SR; Wall A; Thibblin A; Lubberink M; Bundgaard C; Brennum LT; Steiniger-Brach B; Christoffersen CT; Timmermann S; Kreilgaard M; Antoni G; Bang-Andersen B; Nielsen J
    J Nucl Med; 2014 Sep; 55(9):1513-8. PubMed ID: 24994928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical Characterization of the Phosphodiesterase 10A PET Tracer [(11)C]MK-8193.
    Hostetler ED; Fan H; Joshi AD; Zeng Z; Eng W; Gantert L; Holahan M; Meng X; Miller P; O'Malley S; Purcell M; Riffel K; Salinas C; Williams M; Ma B; Buist N; Smith SM; Coleman PJ; Cox CD; Flores BA; Raheem IT; Cook JJ; Evelhoch JL
    Mol Imaging Biol; 2016 Aug; 18(4):579-87. PubMed ID: 26596571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of chronic antipsychotic treatment on striatal phosphodiesterase 10A levels: a [¹¹C]MP-10 PET rodent imaging study with ex vivo confirmation.
    Natesan S; Ashworth S; Nielsen J; Tang SP; Salinas C; Kealey S; Lauridsen JB; Stensbøl TB; Gunn RN; Rabiner EA; Kapur S
    Transl Psychiatry; 2014 Apr; 4(4):e376. PubMed ID: 24690597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.